Lyka Labs Secures Indian Patent for Pregabalin Gel for Neuropathic Pain

Lyka Labs Limited has revealed that it has received an Indian Patent for its unique product, Pregabalin Gel 8 percent, with patent protection lasting until 2043.

Experts Urge Review of Pharma Imports as US Tariff Barriers Rise

Industry leaders want the Indian government to undertake an entire impact and vulnerability study to identify the risk associated with importing...

AstraZeneca India gets CDSCO nod to import, distribute Osimertinib drug

AstraZeneca Pharma India Limited has received the authorization from the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, to import and market Osimertinib Tablets 40 mg & 80 mg....

Domestic MedTech industry opposes Gujarat's stent pricing favoring USFDA devices

In India's medical device industry, the Gujarat government's recent plan to impose a separate pricing system for drug-eluting stents (DES) has sparked controversy. The new regulation sets the price of stents that have been approved by the US Food....

Indian Pharma Gets Relief, but Medical Device Makers Face Tariff Challenges

The 'reciprocal tariff' plans of US President Donald Trump do not cover pharmaceuticals, thus, emphasizing the significance of...

India Eyes growth in Medical Devices Amid Changing Global Trade trends

India's medical device sector stands to benefit from shifting trade dynamics, especially with the introduction of recent tariffs by the US that reduce the...

India's Pharma sector Receives Relief from Trump's Reciprocal Tariff

U.S. President Donald Trump implemented new reciprocal tariffs but excluded pharmaceuticals, energy, and specific minerals to provide relief to India’s generic drug industry. The White House's factsheet stated...

Health Ministry urges states to ensure regular reporting of organ transplant data

The Health Ministry has requested the states that expressed "serious concern" about hospitals not sharing data on organ transplantations and registering them in the National Transplant Registry to submit short status reports every month.In its letter

India Plans to Train Foreign Nations on best Drug regulatory practices

According to the directors, India may soon begin training foreign drug regulators on drug regulatory practices and pharmacovigilance. The initiative may involve regulators and inspectors from African, Southeast Asian, and SAARC nations under the...

Akums Paving the Way for a Greener Future with Rooftop Solar Power Plant

Haridwar, Uttarakhand – Akums, India's pioneering CDMO and one of the early starters in the business of pharma manufacturing, is making a large stride towards a greener and more sustainable tomorrow. Akums has successfully installed a 600 kWp on-grid

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring